GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Restart Life Sciences Corp (OTCPK:NMLSF) » Definitions » Cyclically Adjusted Book per Share

NMLSF (Restart Life Sciences) Cyclically Adjusted Book per Share : $0.41 (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Restart Life Sciences Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Restart Life Sciences's adjusted book value per share for the three months ended in Dec. 2024 was $-0.012. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.41 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Restart Life Sciences's average Cyclically Adjusted Book Growth Rate was -25.70% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -40.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -42.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Restart Life Sciences was -21.00% per year. The lowest was -48.10% per year. And the median was -39.70% per year.

As of today (2025-05-17), Restart Life Sciences's current stock price is $0.057. Restart Life Sciences's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2024 was $0.41. Restart Life Sciences's Cyclically Adjusted PB Ratio of today is 0.14.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Restart Life Sciences was 0.45. The lowest was 0.04. And the median was 0.12.


Restart Life Sciences Cyclically Adjusted Book per Share Historical Data

The historical data trend for Restart Life Sciences's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Restart Life Sciences Cyclically Adjusted Book per Share Chart

Restart Life Sciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.11 2.96 1.05 0.71 0.41

Restart Life Sciences Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.71 0.93 0.93 0.82 0.41

Competitive Comparison of Restart Life Sciences's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, Restart Life Sciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Restart Life Sciences's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Restart Life Sciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Restart Life Sciences's Cyclically Adjusted PB Ratio falls into.


;
;

Restart Life Sciences Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Restart Life Sciences's adjusted Book Value per Share data for the three months ended in Dec. 2024 was:

Adj_Book= Book Value per Share /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.012/127.3637*127.3637
=-0.012

Current CPI (Dec. 2024) = 127.3637.

Restart Life Sciences Quarterly Data

Book Value per Share CPI Adj_Book
201503 0.054 99.789 0.069
201506 -0.092 100.500 -0.117
201509 -0.013 100.421 -0.016
201512 0.122 99.947 0.155
201603 0.077 101.054 0.097
201606 0.066 102.002 0.082
201609 -0.050 101.765 -0.063
201612 0.247 101.449 0.310
201703 0.312 102.634 0.387
201706 0.306 103.029 0.378
201709 0.000 103.345 0.000
201712 0.901 103.345 1.110
201803 1.936 105.004 2.348
201806 1.872 105.557 2.259
201809 1.827 105.636 2.203
201812 1.694 105.399 2.047
201903 1.643 106.979 1.956
201906 1.564 107.690 1.850
201909 1.530 107.611 1.811
201912 1.480 107.769 1.749
202003 1.354 107.927 1.598
202006 0.864 108.401 1.015
202009 0.855 108.164 1.007
202012 0.187 108.559 0.219
202103 0.294 110.298 0.339
202106 0.271 111.720 0.309
202109 0.193 112.905 0.218
202112 0.032 113.774 0.036
202203 0.086 117.646 0.093
202206 0.066 120.806 0.070
202209 0.049 120.648 0.052
202212 0.002 120.964 0.002
202303 -0.006 122.702 -0.006
202306 0.000 124.203 0.000
202309 -0.030 125.230 -0.031
202312 -0.041 125.072 -0.042
202403 -0.048 126.258 -0.048
202406 -0.051 127.522 -0.051
202409 -0.029 127.285 -0.029
202412 -0.012 127.364 -0.012

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Restart Life Sciences  (OTCPK:NMLSF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Restart Life Sciences's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.057/0.41
=0.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Restart Life Sciences was 0.45. The lowest was 0.04. And the median was 0.12.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Restart Life Sciences Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Restart Life Sciences's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Restart Life Sciences Business Description

Traded in Other Exchanges
Address
700-838 West Hastings St, Vancouver, BC, CAN, V6C 0A6
Restart Life Sciences Corp is a Canadian life sciences company dedicated to addressing today's health challenges with wellness solutions. It is focus is on creating health foods that address the needs of this community. Its Flagship developments includes Autism Spectrum, Health-Related Foods, Psilocybin Clinical Trial for Fragile X Syndrome, Orphan Drug Designation (FDA and EMA).

Restart Life Sciences Headlines

From GuruFocus

Nova Mentis Files Genetic Neuroinflammatory Disease Patent

By PRNewswire PRNewswire 11-09-2021